These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Nucleoside analogues: 8. Some isomers of B.3839, the original 5-fluorouracil/nitrosourea molecular combination, and their effect on colon, breast and lung tumours in mice. McElhinney RS, McCormick JE, Bibby MC, Double JA, Atassi G, Dumont P, Pratesi G, Radacic M. Anticancer Drug Des; 1989 Jun; 4(1):1-20. PubMed ID: 2757750 [Abstract] [Full Text] [Related]
8. Nucleoside analogues. 13. The effect on anti-tumour activity of varying the uracil 5-substituent and the point of attachment (N1 or N3) of the uracil moiety in seco-nucleoside nitrosoureas. Bibby MC, Double JA, McCormick JE, McElhinney RS, Radacic M, Pratesi G, Dumont P. Anticancer Drug Des; 1993 Apr; 8(2):115-28. PubMed ID: 8494602 [Abstract] [Full Text] [Related]
9. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models. Schmid FA, Sirotnak FM, Otter GM, DeGraw JI. Cancer Treat Rep; 1987 Apr; 71(7-8):727-32. PubMed ID: 3607784 [Abstract] [Full Text] [Related]
10. Sequence-dependent activity of 5-fluorouracil plus tauromustine in a transplantable well-differentiated murine colon adenocarcinoma. Hill SR, Pollard LA, Bibby MC. Anticancer Res; 1992 Apr; 12(6B):2169-75. PubMed ID: 1295464 [Abstract] [Full Text] [Related]
11. Vinflunine potentiates the activity of cisplatin but not 5-fluorouracil in a transplantable murine adenocarcinoma model. Shnyder SD, Cooper PA, Gyselinck N, Hill BT, Double JA, Bibby MC. Anticancer Res; 2003 Apr; 23(6C):4815-20. PubMed ID: 14981930 [Abstract] [Full Text] [Related]
12. Comparison of tumor growth inhibitory and toxic effects of a new fluorouracil--nitrosourea derivative (B-3839). Prajda N, Kralovánszky J, Somfai-Relle S, Gál F, Kerpel-Fronius S. In Vivo; 1988 Apr; 2(2):151-4. PubMed ID: 2979832 [Abstract] [Full Text] [Related]
13. Anti-tumour activity and bone marrow toxicity of chloroethylnitrosocarbamoyl-amino acid derivatives. Matthew AM, Bibby MC, Double JA. Anticancer Res; 1992 Apr; 12(2):361-5. PubMed ID: 1580552 [Abstract] [Full Text] [Related]
14. Comparison between CoFactor and Leucovorin activity applied in combination with 5-fluorouracil against two human colon cancer cell lines. Bjelogrlić SK, Srdić T, Radulović S. J BUON; 2007 Apr; 12(1):71-6. PubMed ID: 17436405 [Abstract] [Full Text] [Related]
15. Pharmacokinetic studies of chloroethylnitrosocarbamoyl-amino acid derivatives in vivo and in vitro. Matthew AM, Bibby MC, Eisenbrand G. Anticancer Res; 1993 Apr; 13(1):81-6. PubMed ID: 8476230 [Abstract] [Full Text] [Related]
16. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo. Kase S, Kubota T, Watanabe M, Furukawa T, Tanino H, Ishibiki K, Teramoto T, Kitajima M. Anticancer Res; 1993 Apr; 13(2):369-73. PubMed ID: 8517649 [Abstract] [Full Text] [Related]